评估布普伦诺芬治疗癌症疼痛:一个系统的审查协议
Rafina Khateeb1,2, Victoria Powell3,4, Jack Rosenberg5,6
1Division of Geriatric and Palliative Medicine, University of Michigan, F7896 UH South, SPC 5233, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109, USA. rafina@umich.edu.
Systematic reviews
|November 11, 2025
概括
本系统性审查总结了布普伦诺啡因.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症疼痛影响了许多患者,通常用阿片类药物来治疗.
- 阿片类药物有影响生活质量的副作用.
- 布普伦诺芬是一种部分片受体 (MOR) 激动剂,越来越多地用于癌症疼痛,但其作用尚未完全理解.
研究的目的:
- 系统地审查和总结关于布普伦诺芬治疗癌症相关疼痛的现有文献.
- 通过各种研究设计和配方来评估布普伦诺芬在治疗癌症疼痛方面的疗效和安全性.
- 识别知识差距,并为未来的研究和临床实践提供信息.
主要方法:
- 在2025年9月,在多个数据库 (Cochrane CENTRAL,Ovid Medline,EMBASE,EBSCO,Web of Science) 进行全面的文献搜索.
- 包括在两个或两个以上的时间点使用验证尺度测量疼痛结果的研究;排除案例研究,定性研究,评论和术后疼痛研究.
- 使用Cochrane ROB 2进行RCT和纽卡斯尔-太华尺度进行观察性研究的质量评估,并根据GRADE标准评估数据.
主要成果:
- 在系统性审查完成后,该部分将被填写.
结论:
- 本系统性审查旨在全面了解布普伦诺芬在癌症疼痛管理中的有效性和安全性.
- 这些发现将有助于解决关于布普伦诺芬在癌症疼痛中的作用的知识差距.
- 结果将为临床实践提供信息,并指导未来的研究方向.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
897
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
897
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
543
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
543
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
657
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
657
Opioid Analgesics: Morphine and Other Natural Cogeners
833
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
833
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


